Benefit of Oxaliplatin in Stage III Colon Cancer According to IDEA Risk Groups: Findings from the ACCENT Database of 4934 Patients.
Clin Colorectal Cancer
; 20(2): 130-136, 2021 06.
Article
in En
| MEDLINE
| ID: mdl-33775561
Full text:
1
Database:
MEDLINE
Main subject:
Organoplatinum Compounds
/
Antineoplastic Combined Chemotherapy Protocols
/
Colonic Neoplasms
/
Oxaliplatin
Type of study:
Clinical_trials
/
Diagnostic_studies
/
Etiology_studies
/
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Limits:
Adult
/
Aged
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
Clin Colorectal Cancer
Journal subject:
GASTROENTEROLOGIA
/
NEOPLASIAS
Year:
2021
Type:
Article
Affiliation country:
Israel